SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-020632
Filing Date
2020-03-23
Accepted
2020-03-23 16:22:25
Documents
2
Period of Report
2020-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7944
2 POA DOCUMENT poa.txt EX-24.4_906145 2982
  Complete submission text file 0001209191-20-020632.txt   12311
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
McDevitt Damien (Reporting) CIK: 0001742277 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38137 | Film No.: 20735144